Literature DB >> 32822289

Asymptomatic Transmission of SARS-CoV-2 on Evacuation Flight.

Sung Hwan Bae, Heidi Shin, Ho-Young Koo, Seung Won Lee, Jee Myung Yang, Dong Keon Yon.   

Abstract

We conducted a cohort study in a controlled environment to measure asymptomatic transmission of severe acute respiratory syndrome coronavirus 2 on a flight from Italy to South Korea. Our results suggest that stringent global regulations are necessary for the prevention of transmission of this virus on aircraft.

Entities:  

Keywords:  COVID-19; Italy; SARS-CoV-2; South Korea; aircraft; asymptomatic transmission; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Mesh:

Year:  2020        PMID: 32822289      PMCID: PMC7588520          DOI: 10.3201/eid2611.203353

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Undocumented cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been common during the coronavirus disease (COVID-19) global pandemic (–). Although inflight transmission of symptomatic COVID-19 has been well established (,), the evidence for transmission of asymptomatic COVID-19 on an aircraft is inconclusive. We conducted a cohort study evaluating asymptomatic passengers on a flight that carried 6 asymptomatic patients with confirmed SARS-CoV-2 infections. The Institutional Review Board of Armed Force Medical Command approved the study protocol. The ethics commission waived written informed consent because of the urgent need to collect data on COVID-19.

The Study

On March 31, 2020, we enrolled in our study 310 passengers who boarded an evacuation flight from Milan, Italy, to South Korea. This evacuation flight was conducted under strict infection control procedures by the Korea Centers for Disease Control and Prevention (KCDC), based on the guidelines of the World Health Organization (WHO) (). When the passengers arrived at the Milan airport, medical staff performed physical examinations, medical interviews, and body temperature checks outside the airport before boarding, and 11 symptomatic passengers were removed from the flight. Medical staff dispatched from KCDC were trained in infection control under the guidance of the KCDC and complied with the COVID-19 infection protocol, which was based on WHO guidelines (). N95 respirators were provided, and passengers were kept 2 m apart for physical distancing during preboarding. Most passengers wore the N95 respirators except at mealtimes and when using the toilet during the flight. After an 11-hour flight, 299 asymptomatic passengers arrived in South Korea and were immediately quarantined for 2 weeks at a government quarantine facility in which the passengers were completely isolated from one another. Medical staff examined them twice daily for elevated body temperature and symptoms of COVID-19. All passengers were tested for SARS-CoV-2 by reverse transcription PCR twice, on quarantine day 1 (April 2) and quarantine day 14 (April 15). Asymptomatic patients were those who were asymptomatic when they tested positive and did not develop symptoms within 14 days after testing (). Among the 299 passengers (median age 30.0 years; 44.1% male), 6 had a confirmed positive result for SARS-CoV-2 on quarantine day 1 and were transferred immediately to the hospital (Table). At 14 days after the positive test, the 6 patients reported no symptoms and were categorized as asymptomatic.
Table

Baseline characteristics and quarantine day 1 SARS-CoV-2 test results for asymptomatic passengers from flight from Milan, Italy, to South Korea, March 2020*

CharacteristicsAll asymptomatic passengers, N = 299Passengers testing negative for SARS-CoV-2, n = 293Patients testing positive for SARS-CoV-2, n = 6
Median age (IQR), y
30.0 (27.0–35.0)
30.0 (27.0–35.0)
28.0 (9.9–45.0)
Sex
M132 (44.1)128 (43.7)4 (66.7)
F
167 (55.9)
165 (56.3)
2 (33.3)
Underlying conditions
Diabetes1 (0.3)1 (0.3)0 (0.0)
Hypertension6 (2.0)6 (2.0)0 (0.0)
Asthma1 (0.3)1 (0.3)0 (0.0)
Coronary artery disease1 (0.3)1 (0.3)0 (0.0)
Cancer3 (1.0)3 (1.0)0 (0.0)
Connective tissue disease1 (0.3)1 (0.3)0 (0.0)
Liver disease1 (0.3)1 (0.3)0 (0.0)
Thyroid disease2 (0.7)2 (0.7)0 (0.0)
Current pregnancy
4 (1.4)
4 (1.4)
0 (0.0)
Charlson Comorbidity Index score
0287 (96.0)281 (95.9)6 (100.0)
18 (2.7)8 (2.7)0 (0.0)
>24 (1.3)4 (1.4)0 (0.0)

*Values are no. (%) except as indicated. IQR, interquartile range; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

*Values are no. (%) except as indicated. IQR, interquartile range; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. On quarantine day 14, a 28-year-old woman who had no underlying disease had a confirmed positive test result for COVID-19. On the flight from Milan, Italy, to South Korea, she wore an N95 mask, except when she used a toilet. The toilet was shared by passengers sitting nearby, including an asymptomatic patient. She was seated 3 rows away from the asymptomatic patient (Figure). Given that she did not go outside and had self-quarantined for 3 weeks alone at her home in Italy before the flight and did not use public transportation to get to the airport, it is highly likely that her infection was transmitted in the flight via indirect contact with an asymptomatic patient. She reported coughing, rhinorrhea, and myalgia on quarantine day 8 and was transferred to a hospital on quarantine day 14. The remaining 292 passengers were released from quarantine on day 15.
Figure

Cohort study of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission on evacuation flight from Milan, Italy, to Incheon, South Korea, on March 31, 2020. Red indicates asymptomatic patients who tested positive on quarantine day 1 (April 1, 2020); blue indicates asymptomatic patient who tested positive on quarantine day 14 (April 15, 2020). A) Timeline of flight, passenger quarantine, and testing protocol. B) Location of 6 asymptomatic patients and subsequently infected patient on flight. C) Case report of patient apparently infected during evacuation flight.

Cohort study of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission on evacuation flight from Milan, Italy, to Incheon, South Korea, on March 31, 2020. Red indicates asymptomatic patients who tested positive on quarantine day 1 (April 1, 2020); blue indicates asymptomatic patient who tested positive on quarantine day 14 (April 15, 2020). A) Timeline of flight, passenger quarantine, and testing protocol. B) Location of 6 asymptomatic patients and subsequently infected patient on flight. C) Case report of patient apparently infected during evacuation flight. All crew members (n = 10) and medical staff dispatched from KCDC (n = 8) were quarantined at a government quarantine facility for 2 weeks and were tested twice for SARS-CoV-2, on quarantine days 1 and 14. All 18 members of the cabin crew and medical staff were negative for SARS-CoV-2 on both occasions. To reinforce our results, we performed an external validation using a different dataset. Another evacuation flight of 205 passengers from Milan, Italy, to South Korea on April 3, 2020, was also conducted by KCDC under strict infection control procedures. Among the passengers on this flight were 3 asymptomatic patients who tested positive on quarantine day 1 and 1 patient who tested negative on quarantine day 1 and positive on quarantine day 14. On the basis of an epidemiologic investigation, the authors and KCDC suspect that this infection was also transmitted by inflight contact.

Conclusions

This study was one of the earliest to assess asymptomatic transmission of COVID-19 on an aircraft. Previous studies of inflight transmission of other respiratory infectious diseases, such as influenza and severe acute respiratory syndrome, revealed that sitting near a person with a respiratory infectious disease is a major risk factor for transmission (,), similar to our own findings. Considering the difficulty of airborne infection transmission inflight because of high-efficiency particulate-arresting filters used in aircraft ventilation systems, contact with contaminated surfaces or infected persons when boarding, moving, or disembarking from the aircraft may play a critical role in inflight transmission of infectious diseases (,). Previous studies reported that viral shedding can begin before the appearance of COVID-19 symptoms (,), and evidence of transmission from presymptomatic and asymptomatic persons has been reported in epidemiologic studies of SARS-CoV-2 (,,). Because KCDC performed strong infection control procedures during boarding; the medical staff and crew members were trained in infection control; all passengers, medical staff, and crew members were tested twice for SARS-CoV-2; and a precise epidemiologic investigation was conducted, the most plausible explanation for the transmission of SARS-CoV-2 to a passenger on the aircraft is that she became infected by an asymptomatic but infected passenger while using an onboard toilet. Other, less likely, explanations for the transmission are previous SARS-CoV-2 exposure, longer incubation period, and other unevaluated situations. The control measures incorporated into our cohort study provide a higher level of evidence than previous studies on asymptomatic transmission (,,). Our findings suggest the following strategies for the prevention of SARS-CoV-2 transmission on an aircraft. First, masks should be worn during the flight. Second, because contact with contaminated surfaces increases the risk for transmission of SARS-CoV-2 among passengers, hand hygiene is necessary to prevent infections. Third, physical distance should be maintained before boarding and after disembarking from the aircraft. Our research provides evidence of asymptomatic transmission of COVID-19 on an airplane. Further attention is warranted to reduce the transmission of COVID-19 on aircraft. Our results suggest that stringent global regulations for the prevention of COVID-19 transmission on aircraft can prevent public health emergencies.
  10 in total

1.  In-flight transmission cluster of COVID-19: a retrospective case series.

Authors:  Naibin Yang; Yuefei Shen; Chunwei Shi; Ada Hoi Yan Ma; Xie Zhang; Xiaomin Jian; Liping Wang; Jiejun Shi; Chunyang Wu; Guoxiang Li; Yuan Fu; Keyin Wang; Mingqin Lu; Guoqing Qian
Journal:  Infect Dis (Lond)       Date:  2020-07-31

2.  Temporal dynamics in viral shedding and transmissibility of COVID-19.

Authors:  Xi He; Eric H Y Lau; Peng Wu; Xilong Deng; Jian Wang; Xinxin Hao; Yiu Chung Lau; Jessica Y Wong; Yujuan Guan; Xinghua Tan; Xiaoneng Mo; Yanqing Chen; Baolin Liao; Weilie Chen; Fengyu Hu; Qing Zhang; Mingqiu Zhong; Yanrong Wu; Lingzhai Zhao; Fuchun Zhang; Benjamin J Cowling; Fang Li; Gabriel M Leung
Journal:  Nat Med       Date:  2020-04-15       Impact factor: 53.440

3.  Presumed Asymptomatic Carrier Transmission of COVID-19.

Authors:  Yan Bai; Lingsheng Yao; Tao Wei; Fei Tian; Dong-Yan Jin; Lijuan Chen; Meiyun Wang
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

4.  Transmission of the severe acute respiratory syndrome on aircraft.

Authors:  Sonja J Olsen; Hsiao-Ling Chang; Terence Yung-Yan Cheung; Antony Fai-Yu Tang; Tamara L Fisk; Steven Peng-Lim Ooi; Hung-Wei Kuo; Donald Dah-Shyong Jiang; Kow-Tong Chen; Jim Lando; Kwo-Hsiung Hsu; Tzay-Jinn Chen; Scott F Dowell
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

Review 5.  Transmission of infectious diseases during commercial air travel.

Authors:  Alexandra Mangili; Mark A Gendreau
Journal:  Lancet       Date:  2005 Mar 12-18       Impact factor: 79.321

6.  Covid-19 in South Korea - Challenges of Subclinical Manifestations.

Authors:  Joon-Young Song; Jin-Gu Yun; Ji-Yun Noh; Hee-Jin Cheong; Woo-Joo Kim
Journal:  N Engl J Med       Date:  2020-04-06       Impact factor: 91.245

7.  SARS-CoV-2 Infection among Travelers Returning from Wuhan, China.

Authors:  Oon-Tek Ng; Kalisvar Marimuthu; Po-Ying Chia; Vanessa Koh; Calvin J Chiew; Liang De Wang; Barnaby E Young; Monica Chan; Shawn Vasoo; Li-Min Ling; David C Lye; Kai-Qian Kam; Koh-Cheng Thoon; Lalitha Kurupatham; Zubaidah Said; Ethan Goh; Constance Low; Soon-Kok Lim; Pream Raj; Olivia Oh; Valerie T J Koh; Cuiqin Poh; Tze-Minn Mak; Lin Cui; Alex R Cook; Raymond T P Lin; Yee-Sin Leo; Vernon J M Lee
Journal:  N Engl J Med       Date:  2020-03-12       Impact factor: 91.245

8.  Epidemiology and clinical features of coronavirus disease 2019 in children.

Authors:  Soo-Han Choi; Han Wool Kim; Ji-Man Kang; Dong Hyun Kim; Eun Young Cho
Journal:  Clin Exp Pediatr       Date:  2020-04-06

9.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.

Authors:  Melissa M Arons; Kelly M Hatfield; Sujan C Reddy; Anne Kimball; Allison James; Jesica R Jacobs; Joanne Taylor; Kevin Spicer; Ana C Bardossy; Lisa P Oakley; Sukarma Tanwar; Jonathan W Dyal; Josh Harney; Zeshan Chisty; Jeneita M Bell; Mark Methner; Prabasaj Paul; Christina M Carlson; Heather P McLaughlin; Natalie Thornburg; Suxiang Tong; Azaibi Tamin; Ying Tao; Anna Uehara; Jennifer Harcourt; Shauna Clark; Claire Brostrom-Smith; Libby C Page; Meagan Kay; James Lewis; Patty Montgomery; Nimalie D Stone; Thomas A Clark; Margaret A Honein; Jeffrey S Duchin; John A Jernigan
Journal:  N Engl J Med       Date:  2020-04-24       Impact factor: 91.245

10.  Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching.

Authors:  Seung Won Lee; Eun Kyo Ha; Abdullah Özgür Yeniova; Sung Yong Moon; So Young Kim; Hyun Yong Koh; Jee Myung Yang; Su Jin Jeong; Sun Joon Moon; Joo Young Cho; In Kyung Yoo; Dong Keon Yon
Journal:  Gut       Date:  2020-07-30       Impact factor: 31.793

  10 in total
  31 in total

1.  Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Among Air Passengers in China.

Authors:  Maogui Hu; Jinfeng Wang; Hui Lin; Corrine W Ruktanonchai; Chengdong Xu; Bin Meng; Xin Zhang; Alessandra Carioli; Yuqing Feng; Qian Yin; Jessica R Floyd; Nick W Ruktanonchai; Zhongjie Li; Weizhong Yang; Andrew J Tatem; Shengjie Lai
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

2.  Recently spreading human monkeypox virus infection and its transmission during COVID-19 pandemic period: A travelers' prospective.

Authors:  Manojit Bhattacharya; Kuldeep Dhama; Chiranjib Chakraborty
Journal:  Travel Med Infect Dis       Date:  2022-06-29       Impact factor: 20.441

3.  Adsorption of SARS CoV-2 spike proteins on various functionalized surfaces correlates with the high transmissibility of Delta and Omicron variants.

Authors:  Daniela Dobrynin; Iryna Polishchuk; Lotan Portal; Ivan Zlotver; Alejandro Sosnik; Boaz Pokroy
Journal:  Mater Today Bio       Date:  2022-04-19

4.  Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces shedding of SARS-CoV-2 D614G in rhesus macaques.

Authors:  Neeltje van Doremalen; Jyothi N Purushotham; Jonathan E Schulz; Myndi G Holbrook; Trenton Bushmaker; Aaron Carmody; Julia R Port; Claude K Yinda; Atsushi Okumura; Greg Saturday; Fatima Amanat; Florian Krammer; Patrick W Hanley; Brian J Smith; Jamie Lovaglio; Sarah L Anzick; Kent Barbian; Craig Martens; Sarah Gilbert; Teresa Lambe; Vincent J Munster
Journal:  bioRxiv       Date:  2021-01-11

Review 5.  In the interest of public safety: rapid response to the COVID-19 epidemic in Vietnam.

Authors:  Thuong Vu Nguyen; Quang Dai Tran; Lan Trong Phan; Long Ngoc Vu; Dung Thi Thuy Truong; Hieu Cong Truong; Tu Ngoc Le; Linh Dang Khanh Vien; Thinh Viet Nguyen; Quang Chan Luong; Quang Duy Pham
Journal:  BMJ Glob Health       Date:  2021-01

6.  Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.

Authors:  Youn Ho Shin; Jae Il Shin; Sung Yong Moon; Hyun Young Jin; So Young Kim; Jee Myung Yang; Seong Ho Cho; Sungeun Kim; Minho Lee; Youngjoo Park; Min Seo Kim; Hong-Hee Won; Sung Hwi Hong; Andreas Kronbichler; Ai Koyanagi; Louis Jacob; Lee Smith; Keum Hwa Lee; Dong In Suh; Seung Won Lee; Dong Keon Yon
Journal:  Lancet Rheumatol       Date:  2021-06-18

7.  Infection Prevention Performance among In-Flight Cabin Crew in South Korea.

Authors:  Jaegeum Ryu; Jungha Kim; Smi Choi-Kwon
Journal:  Int J Environ Res Public Health       Date:  2021-06-15       Impact factor: 3.390

8.  In-flight transmission of SARS-CoV-2: a review of the attack rates and available data on the efficacy of face masks.

Authors:  David O Freedman; Annelies Wilder-Smith
Journal:  J Travel Med       Date:  2020-12-23       Impact factor: 8.490

9.  Flight-Associated Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Corroborated by Whole-Genome Sequencing.

Authors:  Hollie Speake; Anastasia Phillips; Tracie Chong; Chisha Sikazwe; Avram Levy; Jurissa Lang; Benjamin Scalley; David J Speers; David W Smith; Paul Effler; Suzanne P McEvoy
Journal:  Emerg Infect Dis       Date:  2020-09-29       Impact factor: 6.883

10.  A large national outbreak of COVID-19 linked to air travel, Ireland, summer 2020.

Authors:  Nicola Murphy; Máirín Boland; Niamh Bambury; Margaret Fitzgerald; Liz Comerford; Niamh Dever; Margaret B O'Sullivan; Naomi Petty-Saphon; Regina Kiernan; Mette Jensen; Lois O'Connor
Journal:  Euro Surveill       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.